Previous Article | Next Article 
Journal of Virology, May 2000, p. 4155-4164, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Simian Immunodeficiency Virus Containing Mutations
in N-Terminal Tyrosine Residues and in the PxxP Motif in Nef
Replicates Efficiently in Rhesus Macaques
Silke
Carl,1
A.
John
Iafrate,2
Sabine M.
Lang,1
Nicole
Stolte,3
Christiane
Stahl-Hennig,3
Kerstin
Mätz-Rensing,3
Dietmar
Fuchs,4
Jacek
Skowronski,2 and
Frank
Kirchhoff1,*
Institute for Clinical and Molecular
Virology, University of Erlangen-Nuernberg, 91054 Erlangen,1 and German Primate
Center, 37077 Göttingen,3 Germany;
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
117242; and Institute of Medical
Chemistry and Biochemistry, University of Innsbruck, and Ludwig
Bolzmann Institute of AIDS Research, A-6020 Innsbruck,
Austria4
Received 7 December 1999/Accepted 8 February 2000
 |
ABSTRACT |
SIVmac Nef contains two N-terminal tyrosines that were proposed to
be part of an SH2-ligand domain and/or a tyrosine-based endocytosis
signal and a putative SH3-ligand domain
(P104xxP107). In the present study, we
investigated the effects of combined mutations in these tyrosine and
proline residues on simian immunodeficiency virus (SIV) Nef
interactions with the cellular signal transduction and endocytic
machinery. We found that mutation of Y28F,
Y39F, P104A, and P107A (FFAA-Nef)
had little effect on Nef functions such as the association with the
cellular tyrosine kinase Src, downregulation of cell surface expression
of CD4 and class I major histocompatibility complex, and enhancement of
virion infectivity. However, mutations in the PxxP sequence reduced the
ability of Nef to stimulate viral replication in primary lymphocytes.
Three macaques infected with the SIVmac239 FFAA-Nef variant showed high viral loads during the acute phase of infection. Reversions in the
mutated prolines were observed between 12 and 20 weeks postinfection. Importantly, reversion of A107
P, which restored the
ability of Nef to coprecipitate a 62-kDa phosphoprotein in in vitro
kinase assays, did not precede the development of a high viral load. The Y28/Y39
F28/F39
substitutions did not revert. In conclusion, mutations in both the
tyrosine residues and the putative SH3 ligand domain apparently do not
disrupt major aspects of SIV Nef function in vivo.
 |
INTRODUCTION |
An intact nef gene is
important for efficient replication and pathogenicity of human and
simian immunodeficiency viruses (HIV and SIV, respectively) (14,
31, 34, 63). Several in vitro activities of HIV and SIV Nef which
may be relevant for viral pathogenicity have been described. Nef
downregulates cell surface expression of CD4 (2, 6, 20, 46)
and of class I major histocompatibility complex (MHC-I) molecules
(12, 40, 56). Furthermore, Nef increases the infectivity of
viral particles and enhances viral replication in primary lymphocytes
(11, 16, 22, 37, 42, 47, 58).
Although the molecular basis of these effects has not been fully
elucidated, several studies have shown that Nef can interfere with
cellular signal transduction pathways (1, 4, 17, 24, 29, 43,
57) and interacts with a number of cellular proteins and kinases
(reviewed in reference 54). It has been shown
previously that the conserved P(xxP)3 element in HIV type 1 (HIV-1) Nef is important for the association with a 62-kDa
phosphoprotein, termed Nef-associated kinase (NAK), which may belong to
the family of p21-activated protein kinases (5, 45, 48, 55).
The PxxP motif of HIV-1 Nef also mediates the interaction with the SH3
domains of the Src tyrosine family kinases Hck, Lyn, and Fyn and the
SH3 domain of VAV (3, 18, 25, 38, 39, 53). Since
p21-activated protein kinases do not contain SH3 domains and are
unlikely to interact directly with the PxxP sequence in Nef, it has
been suggested that an SH3 domain-containing tyrosine kinase, p62, and
HIV-1 Nef may form a protein complex (45). Recently, it has
been suggested that HIV-1 Nef association with the
chain of the
T-cell receptor complex activates NAK and leads to the induction of
Fas-Fas ligand expression (64).
A P(xxP)1-2 motif is also conserved in SIV and HIV-2 Nef.
Similarly to HIV-1 Nef, mutations in the PxxP motif in SIV Nef can disrupt association with p62 (32, 37). Mutation of the PxxP motif in SIVmac Nef, however, does not impair tyrosine or serine phosphorylation of Nef and does not disrupt the interaction with the
tyrosine kinase Src (37). Furthermore, we have
previously found that SIVmac239 containing changes of
P104xxP107 to
A104xxA107 in Nef (AxxA-Nef) showed full
pathogenic potential in rhesus macaques (37).
A107
P reversion, which is sufficient to restore the
Nef-p62 association, was observed in only a minor fraction of
nef sequences derived from rapidly progressing animals at
the time of AIDS-related death at 9 and 18 weeks postinfection (wpi)
(37). In another study, however, such reversions came to
predominate in the majority of macaques chronically infected with the
SIVmac239 AxxA-Nef mutant (32).
Notably, the SIVmac Nef protein, unlike HIV-1 Nef, contains
N-terminal Y28xxL/Y39xxS motifs, which resemble
consensus sequences for SH2 binding domains (17). An
SIVmac239 variant containing an additional YxxL motif in Nef,
which generates an immunoreceptor tyrosine-based activation motif,
causes extensive T-lymphocyte activation and acute disease in macaques
(17, 43). It has also been postulated that the
Y28GRL/Y39SQS motifs in SIV Nef may represent
tyrosine-based endocytosis signals important for downregulation of CD4
(8, 49).
One possible explanation for why mutations of the PxxP motif in SIV Nef
do not prevent disease progression in macaques is that SIV Nef, unlike
HIV-1 Nef, interacts with both SH2 and SH3 domains to perform critical
functions. In the present study, we assessed this possibility and
further investigated the relevance of the Nef-NAK association for SIV
replication in vivo. A Nef mutant containing combined changes in both
the proline- and the tyrosine-based motifs (FFAA-Nef) associated with
the cellular tyrosine kinase Src and was functional in most in vitro
assay systems. The FFAA-Nef did not associate with p62, however, and showed a reduced ability to stimulate viral replication in primary lymphocytes. SIVmac239 containing the FFAA-Nef replicated to high levels in infected rhesus macaques. Concordant with previous studies (32, 37), we show that
A104xxA107
P104xxP107
reversions are not a prerequisite for efficient replication of SIVmac
in rhesus macaques. The
Y28/Y39
F28/F39
substitutions did not revert, suggesting that these N-terminal
tyrosines in SIV Nef are dispensable for efficient viral replication in vivo.
 |
MATERIALS AND METHODS |
Construction of SIVmac239 Nef mutants and expression
plasmids.
The open SIVmac239 wild-type nef (239wt); the
AxxA-Nef mutant, SIVmac239 nef*, containing a stop signal at
the 93rd codon; and
NU, containing deletions of 515 bp in the
nef-long terminal repeat region, have been previously
described (26, 30, 37, 52). The 239wt nef was
amplified using the mutagenic primer pSIV-YYFF
(5'- GAAGATCTGCGACAGAGACTCTTGCGGGCGCGTGGGGAGACTTT TGGGAGACTCTTAGGAGAGGTGGAAGATGGATTCTCGCAATC-3'), which
introduced two A
T substitutions (underlined) at nucleotide positions
83 and 116 in nef, and primer SL17
(5'-GTCCCTGCTGTTTCAGCGAGTTTCC-3'). The PCR product was
digested with BglII (boldface) and NcoI.
Subsequently, gel-purified fragments encompassing bp 43 to 205 of the
nef open reading frame, predicting changes of
Y28F and Y39F (Fig. 1), were inserted into
plasmids carrying the 239wt, AxxA, AxxP, and PxxA nef
alleles. The mutant nef alleles were subsequently inserted into a modified pBR322 vector containing the full-length SIVmac239 proviral DNA as described previously (37). These mutants are hereinafter referred to as FF-, FFAA-, FFAP-, and FFPA-Nef variants. For protein expression, these nef open reading frames were
amplified with primers SL1 and SL34 and cloned into the expression
vector pFJ as described previously (17). Amplification with
SL34 results in fusion of the AU-1 peptide tag to the C terminus of
Nef. All PCR-derived inserts were sequenced to confirm that only the
intended changes were present (Fig. 1).
Cells, virus stocks, and infectivity assays.
COS, 293T, and
CEMx174 cells were cultured as described previously (9).
Rhesus peripheral blood mononuclear cells (rPBMC) were isolated as
described previously (37), immediately infected with
aliquots of the virus stocks containing 2 ng of p27, and kept in RPMI
1640 with 10% fetal calf serum (FCS). Residual virus was removed by
washing the cells 16 to 18 h after infection. After 6 days
postinfection, cells were stimulated with phytohemagglutinin (PHA; 2 µg/ml; Sigma) for 3 days and washed and maintained in RPMI 1640 with
20% FCS and 100 U of interleukin 2 (IL-2) per ml. Virus production was
measured by reverse transcriptase assay (50). The
herpesvirus saimiri-transformed T-cell line 221 (1) was maintained in the presence of 100 U of IL-2/ml (Boehringer, Heidelberg, Germany) and 20% FCS. Infections were performed in the presence of 50 U of IL-2/ml and 5% FCS. Virus infectivity was determined using sMAGI
cells as described previously (10), except that no
DEAE-dextran was added to the infections, and quantitated using the
Galacto-Light Plus chemiluminescence reporter assay kit (Tropix, Bedford, Mass.), as recommended by the manufacturer.
Transfections.
For virus production, 293T cells were
transfected by the calcium phosphate method (15) with 10 µg of the proviral constructs. The medium was changed after overnight
incubation, and virus was harvested 24 h later. The amount of p27
antigen in the plasma was determined by a commercial HIV-1-HIV-2
enzyme-linked immunosorbent assay (Immunogenetics, Zwijndrecht,
Belgium). COS cells were transfected by the DEAE-dextran method
(13).
Infection of rhesus macaques.
Juvenile rhesus macaques of
Indian origin were infected by intravenous inoculation of SIVmac239
FFAA-Nef, containing 10 ng of p27 produced by transfected 293T cells.
Limiting-dilution analysis in CEMx174 cells showed that the virus
stocks contained approximately 1,000 50% tissue culture infective
doses per ng of p27 antigen. The animals were healthy and seronegative
for SIV, D-type retroviruses, and simian T-cell leukemia virus type 1 at the time of infection. Sera and cells were collected at regular
intervals, and serological, virological, and immunological analysis was
performed as described previously (59-61). Urinary
neopterin levels were determined and normalized for urinary creatine
concentration as previously described (19, 36).
Determination of reversion frequency.
SIV sequences spanning
the entire nef gene were amplified from rPBMC DNA with a
nested-PCR approach or from DNA isolated from positive PBMC-CEMx174
bulk cocultivation by one round of amplification as described
previously (33, 37). Viral plasma RNA was isolated with the
QIAamp RNA kit (Qiagen, Basel, Switzerland), reverse transcribed with
Superscript reverse transcriptase (GibcoBRL, Eggenstein, Germany), and
subjected to a standard nested-PCR approach. PCR fragments were
sequenced directly or following subcloning into the pCRII vector
(Invitrogen Corp., San Diego, Calif.). Sequencing was performed with
the PRISM sequencing kit (Perkin-Elmer, Foster City, Calif.) and with
an automated Applied Biosystems 373 DNA sequencer following the
protocols of the manufacturers. Reversions were quantitated by
comparison to the standard curves as described previously (35,
37).
Biochemical analysis of Nef.
Transfected COS cells or
infected CEMx174 cells were lysed, and cleared cell lysates were used
for immunoprecipitation and in vitro protein kinase assays as described
previously (17, 37). Expression of Nef proteins in whole
cellular lysates was analyzed by immunoblotting (37) as
described by the manufacturer of the enhanced chemiluminescence system
(ECL; Amersham, Chicago, Ill.). Dose-response analysis of the effect of
Nef on CD4 and MHC-I cell surface expression was performed with Jurkat
T cells expressing high levels of CD4, as described previously
(23, 46).
 |
RESULTS |
In vitro replication and infectivity.
The localization of the
mutations introduced into SIVmac239 Nef is shown in Fig.
1. The tyrosines at position 28 and 39 in SIV Nef were replaced with phenylalanines because such mutations disrupt tyrosine-based sorting signals and are known to decrease the
affinity of these signals for adapter complexes by 2 orders of
magnitude (7) and to minimize effects on secondary
structure. In an experiment using high-titered virus stocks derived
from transfected 293T cells, an intact nef gene enhanced SIV
infectivity in sMAGI cells about eightfold (Fig.
2A). The mutations in the tyrosine and
proline residues in SIV Nef did not significantly reduce virion
infectivity.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic presentation of the mutations introduced
into the SIVmac239 Nef. Numbers specify the amino acid
position in Nef. PPT, polypurine tract. Indicated are the mutations in
the N-terminal tyrosine residues and in the PxxP motif.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Infectivity and replication of SIVmac nef
variants. (A) sMAGI cells were infected in triplicate with five
different 293T cell-derived virus stocks containing 100 ng of p27.
Infectivity is shown relative to that of 239wt virus. (B) Replication
kinetics of SIVmac239 nef variants in primary rhesus
lymphocytes. rPBMC were infected immediately after isolation and
stimulated with PHA at day 6 postinfection. Similar results were
obtained with PBMC from three other rhesus macaques. (C) Replication of
the indicated Nef mutants in 221 cells in the presence of 50 U of
IL-2/ml and 5% FCS. Infections, cell culture, and quantitation of
infectivity were performed as described in Materials and Methods.
Reverse transcriptase (RT) activity was determined using a
phosphorimager. P.S.L., photostimulated light emission.
|
|
No significant differences in the replication kinetics of SIVmac239
containing the 239wt,
nef*, FF, AxxA, and FFAA
nef alleles
were observed in CEMx174 cells or prestimulated
rPBMC (data not
shown). The FF-Nef variant replicated with almost the
same efficiency
as 239wt in rPBMC, which were infected immediately
after isolation
and PHA stimulated 6 days later (Fig.
2B). In
comparison, the
AxxA- and FFAA-Nef variants showed a phenotype
intermediate between
those of wild-type and
nef-defective
forms of SIVmac239 (Fig.
2B). The mutations had similar effects on the
ability of Nef to
stimulate SIV replication in the herpesvirus
saimiri-transformed
macaque T-cell line 221 (Fig.
2C). Thus, while
mutations in the
N-terminal tyrosine residues had little effect,
changes in the
PxxP motif reduced the ability of Nef to stimulate viral
replication
about two- to
fivefold.
The Y28F, Y39F, P104A, and
P107A mutations in SIV Nef do not affect the ability to
downregulate CD4 and MHC-I.
The relative abilities of the 239wt
and mutant Nef proteins to downregulate CD4 and MHC-I surface
expression were assayed in dose-response experiments in human
CD4+ Jurkat T cells using a transient-transfection assay.
It has been previously shown that individual mutations in the
N-terminal tyrosine residues or in the PxxP motif did not significantly
affect the ability of SIVmac Nef to downmodulate cell surface
expression of CD4 or MHC-I molecules (37, 41). As shown in
Fig. 3, combining these mutations on the
same Nef molecule also had only a marginal effect on the ability of Nef
to downregulate CD4 and MHC-I molecules.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 3.
The N-terminal tyrosine residues and the PxxP motif in
SIV Nef are dispensable for CD4 and MHC-I downregulation. Human
CD4+ Jurkat T cells were transiently transfected with the
indicated amounts of plasmids expressing the 239wt-, AxxA-, FF-, or
FFAA-Nef, and cell surface expression of CD4 (A) and MHC-I (B) was
determined as described in Materials and Methods. The values on the
y axis give the levels of CD4 and MHC-I expression,
represented by the peak channel number of red or green fluorescence on
CD20+ cells (23, 46).
|
|
P107
A disrupts FFAA-Nef association with NAK
activity.
COS cells were transfected with expression constructs
for 239wt or mutant Nef proteins, and in vitro kinase assays were
performed on Nef immune complexes. Five phosphorylated proteins with
apparent molecular masses of 34, 62, 80, 90, and 110 to 130 kDa (Fig.
4A, lane 2) were detected with 239wt Nef.
A similar pattern was observed for the FF-Nef mutant (Fig. 4, lane 3).
In agreement with previous studies (32, 37), coprecipitation
and/or phosphorylation of these cellular proteins was abolished for
AxxA-Nef (Fig. 4, lane 4). Analysis of mutants containing changes in
single proline residues revealed that the FFAP-Nef showed a pattern of
phosphorylation of proteins similar to that of 239wt Nef, whereas the
FFPA-Nef itself was impaired in the association with cellular
phosphoproteins (Fig. 4A, lanes 5 and 6). All mutant Nef proteins were
expressed at comparable levels as verified by immunoblotting on
whole-cell lysates (Fig. 4A, lower panel). The results show that, of
the four mutations in FFAA-Nef, only P107A is critical for
the association with the serine/threonine kinase that phosphorylates
these substrates. However, all mutant Nef proteins were phosphorylated
in this immune complex kinase assay (Fig. 4A, lanes 3 to 6).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 4.
Kinase association and phosphorylation of mutant SIV Nef
proteins. (A) N-terminal tyrosine residues are not critical for p62
association of SIV Nef. COS cells were transfected with pFJ vector
control (lane 1) or pFJ constructs for 239wt-Nef (lane 2), FF-Nef (lane
3), FFAA-Nef (lane 4), FFPA-Nef (lane 5), or FFAP-Nef (lane 6). Nef
immunocomplexes were precipitated and subjected to in vitro kinase
assays as described previously (17). Labeled proteins were
detected by autoradiography (2 h). Nef expression was detected by
immunoblotting in 15 µg of whole cellular protein as shown in the
lower panel using anti-AU1 antibody. (B) Y28 and
Y39 of SIVmac239 Nef are not required for tyrosine
phosphorylation and Src kinase association. COS cells were transfected
with 5 µg of pFJ expression constructs for Src (Src), 239wt, and FFAA
Nef as indicated. Nef immune complexes were precipitated with anti-AU1
antibodies, and immunoblotted proteins were detected with anti-Src
antibodies (lanes 1 to 6). Src expression was verified by
immunoblotting in 15 µg of whole cellular protein as shown in the
lower panel using anti-Src antibodies (lanes 7 to 12). Molecular size
markers (in kilodaltons) are indicated on the left of each panel. The
positions of Nef, Src, heavy chains (HC), and light chains (LC) are
indicated. IP, immunoprecipitation; IB, immunoblot.
|
|
Tyrosine phosphorylation and Src association.
Expression
constructs for 239wt and FFAA-Nef were transfected into COS cells
together with pFJ expression constructs for the tyrosine
kinase Src. Nef immune complexes were purified, and
tyrosine phosphorylation was detected by immunoblotting. Both
239wt and FFAA-Nef showed tyrosine phosphorylation and
coprecipitation of a 56-kDa tyrosine-phosphorylated protein (Fig.
4B). To verify that the tyrosine-phosphorylated 56-kDa protein in
Nef immune complexes is indeed Src, the membrane was reprobed with an
anti-Src antibody. Src was coprecipitated together with 239-Nef and
FFAA-Nef (Fig. 4B, lower panel). Thus, these tyrosine and proline
residues in SIV-Nef are not required for Src tyrosine kinase
association or Nef tyrosine phosphorylation.
Clinical findings in macaques infected with the SIVmac239
FFAA-Nef variant.
Three rhesus macaques (Mm7999, Mm8154, and
Mm8324) were inoculated intravenously with the SIVmac239 FFAA-Nef
variant. All animals showed a moderate transient anemia by 2 wpi and
developed high titers of SIV-specific antibodies (Fig.
5A). At three time points prior to
infection, the absolute number of CD4+ cells ranged from
1,228 to 2,665/mm3 in these juvenile rhesus macaques
(2,168 ± 303/mm3; n = 9). All animals
showed a marked reduction of CD4+ T cells during acute
infection (day 0, 2,111 ± 390/mm3; 2 wpi, 789 ± 235/mm3; 4 wpi, 678 ± 295/mm3) (Fig.
5B). The decline was most apparent for the
CD4+/CD29+ memory T-cell subset (day 0, 226 ± 47/mm3; 2 wpi, 34 ± 3/mm3; 4 wpi, 48 ± 12/mm3). In agreement with the
declining CD4+ cell counts, the average T4/T8 ratio also
declined from 1.38 ± 0.19 to 0.65 ± 0.20 within the first 2 weeks after inoculation. All animals became chronically infected and
maintained CD4+ lymphocyte counts of >300/mm3
during 68 (Mm7999), 39 (Mm8154), and 98 (Mm824) weeks of follow-up (Fig. 5B). Mm7999 showed a mild (8 wpi) to moderate (16 wpi)
lymphadenopathy and severe splenomegaly by 24 wpi. Mm7999 was
euthanatized at 68 wpi because of a neoplasia at the right eye.
Postmortem examination revealed an obstructive infiltratively growing
malignant B-cell lymphoma at the right orbit and a moderate to severe
hyperplasia to depletion of the lymphatic organs. The second animal,
Mm8154, developed a moderate to marked lymphadenopathy by 12 wpi and a severe splenomegaly by 24 wpi. Mm8154 became anemic by 36 wpi, as
indicated by decreased hemoglobin values (101 g/liter versus a median
prevalue of 129 ± 5 g/liter; n = 5), a reduced
hematocrit (29.3% versus a median prevalue of [38.6 ± 1.5]%;
n = 5), and a reduced number of erythrocytes (4.5 Tera/liter versus a prevalue of 5.4 ± 0.1 Tera/liter;
n = 5). The animal lost approximately 20% of its body
weight during the last 7 weeks of life and had to be euthanatized at 39 wpi because of weakness. Histopathologic examination at necropsy
revealed lymphoid hyperplasia and a moderate interstitial pneumonia.
The remaining animal, Mm8324, developed a mild (16 wpi) to moderate (40 wpi) lymphadenopathy and a moderate splenomegaly. Multiple bouts of
diarrhea were observed by 60 wpi and were induced by infections with
Campylobacter strains and protozoans like
Balantidium and Giardia strains. The animal was euthanatized at 98 wpi because of a tumor in the nasal tract. Histopathologic examination at necropsy identified the neoplasia as a
highly malignant B-cell lymphoma. Furthermore, severe follicular hyperplasia of the lymph nodes and spleen and lymphohistiocytic infiltrates with follicular morphology in multiple other organs including brain, liver, kidney, bladder, skin, muscle, and pancreas were observed. Thus, all animals developed signs and symptoms of
immunodeficiency during the course of infection.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 5.
Humoral immune response and CD4+ T-cell
counts in infected macaques. The figure shows SIV enzyme-linked
immunosorbent assay antibody titers (A) and absolute number of
CD4+ T cells in peripheral blood (B) in three macaques,
Mm7999 ( ), Mm8154 ( ), and Mm8324 ( ), infected with the
FFAA-Nef mutant. Mm7999 had to be euthanatized at 68 wpi, and Mm8154
had to be euthanatized at 39 wpi, while Mm8324 was still alive after 98 weeks of follow-up.
|
|
Replication of the SIVmac239 FFAA-Nef variant in vivo.
An
intact nef gene provides a strong replicative advantage
during the acute phase of SIV infection. In macaques infected with nef-open SIVmac239, the peak levels of p27 plasma viremia
were about 64-fold higher than those in animals inoculated with
nef-deletion SIV (Fig. 6A; Table
1). Similar
differences were observed in the peak viral RNA load (Fig. 6B; Table
1). On average, the peak levels of p27 plasma viremia and of viral
RNA in the three animals that received the FFAA-Nef variant were
not significantly lower than for 239wt infection (Table 1).
Together with the two animals previously analyzed (37), we
have investigated five rhesus macaques infected with SIVmac239
containing the P107A substitution in Nef that disrupts p62 association.
Altogether, the peak levels of both p27 viremia and viral RNA did not
differ significantly from those observed in animals inoculated with
pathogenic SIVmac239 (Fig. 6A and B; Table 1). In agreement with
comparable efficiencies of viral replication, the levels of urinary
neopterin, an indicator for immune activation (19), were
approximately 10-fold elevated during acute infection with 239wt and
the FFAA- or AxxA-Nef SIV variants. In contrast, only a threefold
increase was observed after infection with attenuated
nef-deletion forms (Fig. 6C; Table 1). Thus, mutations
that disrupt Nef-NAK association did not attenuate SIVmac replication
in rhesus macaques during the acute phase of infection.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
Peak levels of viral load in rhesus macaques acutely
infected with SIVmac239 Nef variants. The figure shows maximum levels
of p27 plasma antigenemia (A), viral RNA (B), and urinary neopterin (C)
in five animals infected with the FFAA-Nef ( ) or AxxA-Nef ( )
mutant (37). For comparison, values obtained from 4 (A and
C) and 10 (B) macaques infected with NU and from 8 to 12 animals
infected with 239wt are indicated. Peak levels of p27 plasma
antigenemia and of viral RNA were always observed at 2 wpi. The
neopterin/creatine ratio is expressed for each animal as the fold
increase over the mean ratio determined prior to infection. Mean values
were obtained from at least three samples taken within a 5-day interval
and peaked between 5 and 10 or 11 and 15 days postinfection.
|
|
Early in infection, the cell-associated viral load is relatively high
even in
nef-deletion virus infection (
31).
However,
it drops rapidly to often undetectable levels after 12 wpi
(
31)
(Fig.
7A). In Mm7999 and
Mm8154, the cell-associated viral load
was similar to that for 239wt
infection throughout the course
of infection (Fig.
7A). In the
remaining animal, Mm8324, the cell-associated
viral load was relatively
low at 8 wpi (Fig.
7A). However, two
of nine 239wt-infected macaques
showed a similar decline in viral
load after acute infection (data not
shown). On average, the number
of infectious cells did not differ
significantly between 239wt-
and FFAA-Nef-infected animals (Fig.
7A;
Table
1). In comparison,
after acute infection the average RNA values
were about four-
to eightfold reduced in the macaques inoculated with
the FFAA-Nef
variant, compared to 239wt infection (Fig.
7B; Table
1).
These
RNA levels were 6- to 450-fold higher, however, than the average
values observed for five macaques inoculated with
nef-deletion
SIVmac239 (Fig.
7B; Table
1). In comparison,
the RNA copy numbers
in the two previously analyzed animals infected
with the AxxA-Nef
variant (
37) were high even compared to
239wt infection (data
not shown).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 7.
Replication of the SIVmac239 FFAA-Nef variant in vivo.
The figure shows numbers of infectious cells per 1 million PBMC (A) and
viral RNA loads (B) in Mm7999 ( ), Mm8154 ( ), and Mm8324 ( ),
infected with the FFAA-Nef mutant. The detection limit for viral RNA is
approximately 40 copies/ml (61). For comparison, average
values obtained from 4 (A) and 10 (B) macaques infected with SIVmac239
NU ( ) and from 8 to 12 animals infected with wild-type SIVmac239
( ) are indicated. The grey bars give standard deviations. Parameters
were determined as described in Materials and Methods.
|
|
High viral load precedes reversions in SIVmac239 FFAA-Nef.
To
investigate if the ability of Nef to coprecipitate p62 was restored,
virus was reisolated by cocultivation of PBMC with CEMx174 cells, and
in vitro kinase assays were performed with positive bulk
cocultivations. Significant levels of phenotypic reversions were first
observed at 16 wpi in Mm8324 and at 20 wpi in Mm7999 and Mm8154 (Fig.
8 and data not shown). Notably, at 12 wpi
the cell-associated viral load in these animals was comparable to that
with 239wt infection (Table 1). Genotypic reversions were detected by
direct sequence analysis of nef-spanning PCR fragments
amplified directly from PBMC or from positive bulk cocultivations and
by sequencing of single clones. As summarized in Table
2, changes in codon 107 were first
observed at 16 wpi in Mm7999 and Mm8324 and at 20 wpi in Mm8154.
Concordant with the faint signal at 62 kDa in in vitro kinase assays
(Fig. 8), about 5% of the virus population obtained from Mm7999 at 16 wpi contained reversions (Table 2). Several additional alterations in
nef were detected (Table 2). However, analysis of single
nef alleles derived from the three infected animals
confirmed that only those containing the A107
P reversion
were positive for the Nef-NAK interaction (data not shown). A similar
selective pressure seems to exist for P104, which has no
effect on Nef-NAK association, since in Mm8154 A104
P
reversion was already detected by 8 wpi (Table 2). In Mm8324, a complex
pattern of changes to proline residues at positions 101, 104, and 107 was observed (Table 2 and data not shown). At 16 wpi, two of six
nef alleles predicted the original mutant SxxAxxA sequence,
two contained PxxAxxP, and the remaining two contained PxxAxxA and
SxxAxxP. At 20 wpi, four of six nef alleles predicted
PxxAxxP and two predicted SxxPxxA. Nine of 10 nef alleles
obtained after 20 wpi predicted a PxxPxxP motif. In contrast to the
reversions in the mutated PxxP motif, no changes to N-terminal tyrosine
residues Y28 and Y39 were observed in the three
animals (Table 2). Unexpectedly, however, a F39
S change was first observed at 8 wpi in Mm7999 and came to predominate. Our
results indicate that there is little if any selective pressure for
tyrosine residues at positions 28 and 39 in SIV Nef.

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 8.
Phenotypic reversions of the FFAA-Nef mutant in vivo. In
vitro kinase assays were performed using positive CEMx174-PBMC bulk
cocultivations obtained from Mm7999 at the indicated wpi. Nef and p27
expression levels in the lysates of infected cells were verified by
immunoblotting using rabbit anti-Nef antiserum or a monoclonal anti p27
antibody (27). The right panel shows results obtained from
CEMx174 cells infected with 239nef*, 239wt, and uninfected (uninf.)
cells. Analogous experiments were performed with reisolates recovered
from the remaining two animals infected with the FFAA-Nef mutant.
Nef-NAK association was restored by 20 wpi in Mm8154 and by 16 wpi in
Mm8324. Molecular masses in kilodaltons are shown at left.
|
|
Reversions could occur earlier in viral genomic RNA than in proviral
DNA sequences since RNA represents actively replicating
virus.
Therefore, we analyzed sequences of SIV
nef fragments
amplified
from plasma RNA. Significant levels of reversions in codon
107
could first be detected at 20 wpi in Mm7999 and Mm8154 (Fig.
9).
In the remaining animal, Mm8324, low
levels of reversions in both
codons 104 and 107 were already present at
12 wpi. As with the
proviral DNA analysis, changes of S
101P
were detected in Mm8324
(data not shown), and reversions in codon 104 preceded the change
in codon 107 in Mm8154 (Fig.
9). Overall, the time
frame of reversions
in the mutated PxxP motif was similar in proviral
and in viral
genomic RNA sequences. In comparison, there seems to be
little
if any selective pressure for N-terminal tyrosine residues at
position 28 or 39 in SIVmac Nef. Our findings confirm that in
persistently infected macaques a selective advantage for
P
104 and P
107 in SIVmac Nef exists but also
show that reversions did
not precede efficient viral replication in
vivo.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 9.
Detection of reversions in codons 104 and 107 of the
nef open reading frame in plasma RNA. Viral plasma RNA was
isolated, reverse transcribed, and subjected to nested PCR. DNA
fragments were sequenced directly, and the percentage of reversions
(Rev) was estimated from standard curves as described previously
(37). Only the first positions of codons 104 and 107 are
shown, since nucleotide substitutions in the third position do not
change the amino acid sequence. Nucleotides are shown in black (G) and
grey (C). Numbers below the curves indicate the percentages of GC CC
(A P) reversions.
|
|
 |
DISCUSSION |
In the present study, changes in the mutated PxxP motif that
restored the Nef-NAK association were consistently observed between 12 and 20 wpi. These observations are similar to those made by Khan et al.
(32), who found reversion of AxxA to AxxP in four out of
seven infected macaques and reversion to PxxP in one animal. In the
remaining two animals studied by Khan et al. and in our initial study,
reversions were not observed (32, 37). Therefore, these
three studies consistently indicate that the selective pressure for
prolines at positions 104 and 107 in SIV Nef is weak, because (i)
reversions occurred slowly, compared to inactivating point mutations in
nef (31); (ii) they did not precede the
development of a high viral load; and (iii) several macaques progressed
to fatal disease in the virtual absence of viruses containing
reversions of the AxxA mutations. The present study also demonstrates
that mutations in the N-terminal tyrosine residues in SIV Nef, which were postulated to be important for the interaction of 239 Nef with
adapter protein complexes (49), have little effect on Nef function in vivo.
The initial studies on the role of Nef in SIV pathogenesis showed that
single point mutations that disrupt the nef open reading frame revert within 1 to 2 weeks after inoculation and multiple mutations or deletions that impair important aspects of Nef function result in an attenuated phenotype prior to reversion (9, 31, 62). Altogether, 12 rhesus macaques have been infected with SIVmac239 variants carrying nef alleles predicting a
107P
A (CCC
GCC) change that disrupts Nef association with NAK
(32, 37). Four of these animals died in the virtual absence
of revertant viruses (32, 37). Reversions prior to
AIDS-related death were observed in the remaining eight animals. It has
been suggested that the putative SH3-ligand domain plays an important
role in SIV-induced immunodeficiency, because reversions were observed
in most infected animals (32). However, this finding is
reminiscent of the results from previous studies of vpr.
Point mutations in the SIVmac239 vpr initiation codon
reverted in three of five infected rhesus macaques within 4 to 8 weeks
after inoculation (36). While the initial conclusion from
those experiments was that vpr is important for both SIV
replication in vivo and disease progression, subsequent studies
revealed that a vpr deletion mutant replicated with kinetics similar to that of wild-type SIVmac239 and induced AIDS and death in
infected macaques (21, 28). The finding that reversions in
the mutated SIVmac Nef PxxP motif do not precede the development of a
high viral load and occur only at late time points and only in a subset
of animals that develop fatal disease provides evidence that these
reversions are not required for efficient replication or AIDS progression.
Mutations in the PxxP motif in SIV Nef reduced the ability of Nef to
stimulate viral replication in rPBMC. Surprisingly, the reduced
replicative capacity of the SIVmac239 FFAA-Nef variant in vitro was not
associated with a significant delay in replication kinetics or a
markedly reduced viral load in acutely infected rhesus macaques. One
possible explanation for why revertants are not seen early in infection
is that full activity of Nef to stimulate SIV replication in rPBMC may
be less important during the acute phase of infection, when a
relatively high proportion of T lymphocytes might be already activated.
Immune cell activation during acute infection is evident in increased
levels of neopterin in serum (Table 1), and it has been shown
previously that this serologic activation marker correlates with cell
surface activation markers (51). Consistent with this
hypothesis, few or no reversions in the mutated PxxP motif were
observed in three rapidly progressing macaques, which showed high
levels of immune activation until AIDS-related death (32,
37). Furthermore, in chronically infected macaques changes in the
mutated PxxP motif were consistently observed between 8 and 20 wpi and
not during the acute phase of infection when maximum levels of viral
replication are observed. It is unclear whether this selection is for
the restoration of the Nef-p62 association or for an increased ability
of Nef to stimulate viral replication. We feel that the second is more
likely to be important, because mutations in P104 do also
revert although they do not affect Nef-p62 association. The
P(xxP)3 motifs in HIV-1 Nef likely have higher functional
relevance than the P(xxP)1-2 motifs in SIV Nef based on
accumulated data (23, 29, 32, 37, 44, 53). Consistent with
this, we show that, in contrast to HIV-1 Nef (23, 44), the
PxxP motif in SIV Nef is not required for MHC-I downmodulation.
The N-terminal YxxL/YxxS motifs, which resemble consensus sequences for
SH2 binding domains, are present in SIV but not in HIV-1 Nef. These
tyrosine residues were mutated to investigate their importance for SIV
Nef function, particularly in the absence of an intact putative SH3
domain. We found that the FFAA-Nef was active in CD4 and MHC-I
downregulation and able to enhance virion infectivity. The mutant Nef
also associated with the tyrosine kinase Src and was phosphorylated on
tyrosine residues. Our results indicate that these tyrosine and proline
residues in the context of SIVmac239 Nef are not required for important
interactions with SH2 or SH3 domains. This is in contrast to HIV-1 Nef,
for which a strong interaction between the PxxP motif and the SH3
domain of Src family kinases has been demonstrated previously (3, 25, 38, 39). In addition to possibly being involved in SH2 interactions, it has been reported that tyrosines Y28 and
Y39 may have a role in the association of SIVmac239 Nef
with µ subunits of clathrin-adapter complexes that mediate protein
sorting from the plasma membrane and the Golgi apparatus (8,
49). However, it has also been shown that these tyrosines are not
important for the ability of SIV Nef to downregulate CD4 and MHC-I
molecules, and the interactions of 239-Nef with adapter protein
complexes that are important for CD4 downregulation are mediated by
other sequences in the N-terminal region of the SIV Nef molecule
(41). In the present study, to disrupt the putative SH2
domain binding function of tyrosines Y28 and
Y39 while minimizing the effects of these mutations on
protein folding, these amino acid residues were mutated to
phenylalanines, and as expected, these mutations did not affect the
ability of Nef to downregulate CD4 and MHC-I. No reversions to
tyrosines were detected in the infected animals throughout the
observation period of up to 90 weeks, thus confirming that tyrosines
Y28 and Y39 do not have important roles, either as putative SH2 binding sites or as µ adaptin binding sites, for 239-Nef function or SIV virulence.
In conclusion, our results suggest that mutations in both the tyrosine
residues and the putative SH3 ligand domain do not disrupt major
aspects of SIV Nef function. We confirm previous results (32,
37) showing that the selective pressure for proline residues at
positions 104 and 107 in SIV Nef is weak. More importantly, however,
the viral load prior to reversion is high, suggesting that both the
putative SH3-ligand domain and the N-terminal tyrosine residues in
SIVmac239 Nef do not have major roles for SIV virulence.
 |
ACKNOWLEDGMENTS |
We thank Mandy Krumbiegel and Anne Sterzer for excellent
technical assistance, Ronald C. Desrosiers for helpful comments and sharing unpublished results, and Bernhard Fleckenstein for
constant support and encouragement. We also thank Peter Ten Haaft and
Jonathan Heeney for quantitation of viral RNA loads, Toshiaki
Kodama for providing the full-length SIVmac239 clone, and Julie
Overbaugh and Bryce Chackerian for sMAGI cells.
This work was supported by a Public Health Service grant
(AI42561), Cold Spring Harbor funds (J.S.), the Johannes and Frieda Marohn Foundation, the Wilhelm-Sander Foundation, BMBF grant 01Ki9478, and the Deutsche Forschungsgesellschaft.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute for
Clinical and Molecular Virology, University of Erlangen-Nuernberg,
Schlossgarten 4, 91054 Erlangen, Germany. Phone: 49-9131-852 6483. Fax:
49-9131-852 2101. E-mail:
fkkirchh{at}viro.med.uni-erlangen.de.
 |
REFERENCES |
| 1.
|
Alexander, L.,
Z. Du,
M. Rosenzweig,
J. U. Jung, and R. C. Desrosiers.
1997.
A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.
J. Virol.
71:6094-6099[Abstract].
|
| 2.
|
Anderson, S.,
D. C. Shugars,
R. Swanstrom, and J. V. Garcia.
1993.
Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.
J. Virol.
67:4923-4931[Abstract/Free Full Text].
|
| 3.
|
Arold, S.,
P. Franken,
M. P. Strub,
F. Hoh,
S. Benichou,
R. Benarous, and C. Dumas.
1997.
The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
Structure
5:1361-1372[Medline].
|
| 4.
|
Baur, A. S.,
E. T. Sawai,
P. Dazin,
W. J. Fantl,
C. Cheng-Mayer, and B. M. Peterlin.
1994.
HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization.
Immunity
1:373-384[CrossRef][Medline].
|
| 5.
|
Baur, A. S.,
G. Sass,
B. Laffert,
D. Willbold,
C. Cheng-Mayer, and B. M. Peterlin.
1997.
The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase.
Immunity
6:283-291[CrossRef][Medline].
|
| 6.
|
Benson, R. E.,
A. Sanfridson,
J. S. Ottinger,
C. Doyle, and B. R. Cullen.
1993.
Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.
J. Exp. Med.
177:1561-1566[Abstract/Free Full Text].
|
| 7.
|
Boll, W.,
H. Ohno,
Z. Songyang,
I. Rapoport,
L. C. Cantley,
J. S. Bonifacino, and T. Kirchhausen.
1996.
Sequence requirements for the recognition of tyrosine-based endocytic signals by clathrin AP-2 complexes.
EMBO J.
15:5789-5795[Medline].
|
| 8.
|
Bresnahan, P. A.,
W. Yonemoto, and W. C. Greene.
1999.
Cutting edge: SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for down-regulation of CD4.
J. Immunol.
163:2977-2981[Abstract/Free Full Text].
|
| 9.
|
Carl, S.,
A. J. Iafrate,
S. M. Lang,
C. Stahl-Hennig,
E. M. Kuhn,
D. Fuchs,
K. Mätz-Rensing,
J. Skowronski, and F. Kirchhoff.
1999.
The acidic region and conserved putative protein kinase C phosphorylation site in Nef are important for SIV replication in rhesus macaques.
Virology
257:138-155[CrossRef][Medline].
|
| 10.
|
Chackerian, B.,
N. L. Haigwood, and J. Overbaugh.
1995.
Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates.
Virology
213:386-394[CrossRef][Medline].
|
| 11.
|
Chowers, M. Y.,
C. A. Spina,
T. J. Kwoh,
N. J. Fitch,
D. D. Richman, and J. C. Guatelli.
1994.
Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.
J. Virol.
68:2906-2914[Abstract/Free Full Text].
|
| 12.
|
Collins, K. L.,
B. K. Chen,
S. A. Kalams,
B. D. Walker, and D. Baltimore.
1998.
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Nature
391:397-401[CrossRef][Medline].
|
| 13.
|
Cullen, B. R.
1987.
Use of eukaryotic expression technology in the functional analysis of cloned genes.
Methods Enzymol.
152:684-703[Medline].
|
| 14.
|
Deacon, N. J.,
A. Tsykin,
A. Solomon,
K. Smith,
M. Ludford-Menting,
D. J. Hooker,
D. A. McPhee,
A. L. Greenway,
A. Ellett, and C. Chatfield.
1995.
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.
Science
270:988-991[Abstract/Free Full Text].
|
| 15.
|
Deng, H.,
R. Liu,
W. Ellmeier,
S. Choe,
D. Unutmaz,
M. Burkhart,
P. Di Marzio,
S. Marmon,
R. E. Sutton,
C. M. Hill,
C. B. Davis,
S. C. Peiper,
T. J. Schall,
D. R. Littman, and N. R. Landau.
1996.
Identification of a major co-receptor for primary isolates of HIV-1.
Nature
381:661-666[CrossRef][Medline].
|
| 16.
|
deRonde, A.,
B. Klaver,
W. Keulen,
L. Smit, and J. Goudsmit.
1992.
Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes.
Virology
188:391-395[CrossRef][Medline].
|
| 17.
|
Du, Z.,
S. M. Lang,
V. G. Sasseville,
A. A. Lackner,
P. O. Ilyinskii,
M. D. Daniel,
J. U. Jung, and R. C. Desrosiers.
1995.
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys.
Cell
82:665-674[CrossRef][Medline].
|
| 18.
|
Fackler, O. T.,
W. Luo,
M. Geyer,
A. S. Alberts, and B. M. Peterlin.
1999.
Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions.
Mol. Cell
3:729-739[CrossRef][Medline].
|
| 19.
|
Fendrich, C.,
W. Lüke,
C. Stahl-Hennig,
O. Herchenröder,
D. Fuchs,
H. Wachter, and G. Hunsmann.
1989.
Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiency virus (SIVmac251).
AIDS
3:305-307[Medline].
|
| 20.
|
Garcia, J. V., and A. D. Miller.
1991.
Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.
Nature
350:508-511[CrossRef][Medline].
|
| 21.
|
Gibbs, J. S.,
A. A. Lackner,
S. M. Lang,
M. A. Simon,
P. K. Sehgal,
M. D. Daniel, and R. C. Desrosiers.
1995.
Progression to AIDS in the absence of a gene for vpr or vpx.
J. Virol.
69:2378-2383[Abstract].
|
| 22.
|
Goldsmith, M. A.,
M. T. Warmerdam,
R. E. Atchison,
M. D. Miller, and W. C. Greene.
1995.
Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.
J. Virol.
69:4112-4121[Abstract].
|
| 23.
|
Greenberg, M. E.,
A. J. Iafrate, and J. Skowronski.
1998.
The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.
EMBO J.
17:2777-2789[CrossRef][Medline].
|
| 24.
|
Greenway, A.,
A. Azad, and D. McPhee.
1995.
Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines.
J. Virol.
69:1842-1850[Abstract].
|
| 25.
|
Grzesiek, S.,
A. Bax,
G. M. Clore,
A. M. Gronenborn,
J. S. Hu,
J. Kaufman,
I. Palmer,
S. J. Stahl, and P. T. Wingfield.
1996.
The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase.
Nat. Struct. Biol.
3:340-345[CrossRef][Medline].
|
| 26.
|
Gundlach, B. R.,
H. Linhart,
U. Dittmer,
S. Sopper,
S. Reiprich,
D. Fuchs,
B. Fleckenstein,
G. Hunsmann,
C. Stahl-Hennig, and K. Überla.
1997.
Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin 2.
J. Virol.
71:2225-2232[Abstract].
|
| 27.
|
Higgins, J. R.,
S. Sutjipto,
P. A. Marx, and N. C. Pedersen.
1992.
Shared antigenic epitopes of the major core proteins of human and simian immunodeficiency virus isolates.
J. Med. Primatol.
21:265-269[Medline].
|
| 28.
|
Hoch, J.,
S. M. Lang,
M. Weeger,
C. Stahl-Hennig,
C. Coulibaly,
U. Dittmer,
G. Hunsmann,
D. Fuchs,
J. Muller,
S. Sopper,
B. Fleckenstein, and K. Überla.
1995.
vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys.
J. Virol.
69:4807-4813[Abstract].
|
| 29.
|
Iafrate, A. J.,
S. Bronson, and J. Skowronski.
1997.
Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling.
EMBO J.
16:673-684[CrossRef][Medline].
|
| 30.
|
Kestler, H. W.,
T. Kodama,
D. J. Ringler,
M. Marthas,
N. Pedersen,
A. Lackner,
D. Regier,
P. K. Sehgal,
M. D. Daniel, and R. C. Desrosiers.
1990.
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
Science
248:1109-1112[Abstract/Free Full Text].
|
| 31.
|
Kestler, H. W.,
D. J. Ringler,
K. Mori,
D. L. Panicali,
P. K. Sehgal,
M. D. Daniel, and R. C. Desrosiers.
1991.
Importance of the nef gene for maintenance of high virus loads and for development of AIDS.
Cell
65:651-662[CrossRef][Medline].
|
| 32.
|
Khan, I. H.,
E. T. Sawai,
E. Antonio,
C. J. Weber,
C. P. Mandell,
P. Montbriand, and P. A. Luciw.
1998.
Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques.
J. Virol.
72:5820-5830[Abstract/Free Full Text].
|
| 33.
|
Kirchhoff, F.,
H. W. Kestler, and R. C. Desrosiers.
1994.
Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene.
J. Virol.
68:2031-2037[Abstract/Free Full Text].
|
| 34.
|
Kirchhoff, F.,
T. C. Greenough,
D. B. Brettler,
J. L. Sullivan, and R. C. Desrosiers.
1995.
Absence of intact nef sequences in a long-term, nonprogressing survivor of HIV-1 infection.
N. Engl. J. Med.
332:228-232[Free Full Text].
|
| 35.
|
Kirchhoff, F.,
S. Carl,
S. Sopper,
U. Sauermann,
K. Mätz-Rensing, and C. Stahl-Hennig.
1999.
Selection of the R17Y substitution in SIVmac239 Nef coincided with a dramatic increase in plasma viremia and rapid progression to death.
Virology
254:61-70[CrossRef][Medline].
|
| 36.
|
Lang, S. M.,
C. Weeger,
C. Stahl-Hennig,
C. Coulibaly,
G. Hunsmann,
J. Müller,
H. Müller-Hermelink,
D. Fuchs,
H. Wachter,
M. D. Daniel,
R. C. Desrosiers, and B. Fleckenstein.
1992.
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.
J. Virol.
67:902-912[Abstract/Free Full Text].
|
| 37.
|
Lang, S. M.,
A. J. Iafrate,
C. Stahl-Hennig,
E. M. Kuhn,
T. Nißlein,
M. Haupt,
G. Hunsmann,
J. Skowronski, and F. Kirchhoff.
1997.
Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques.
Nat. Med.
3:860-865[CrossRef][Medline].
|
| 38.
|
Lee, C. H.,
B. Leung,
M. A. Lemmon,
J. Zheng,
D. Cowburn,
J. Kuriyan, and K. Saksela.
1995.
A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein.
EMBO J.
14:5006-5015[Medline].
|
| 39.
|
Lee, C. H.,
K. Saksela,
U. Mirza,
B. Chait, and J. Kuriyan.
1996.
Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain.
Cell
85:931-942[CrossRef][Medline].
|
| 40.
|
Le Gall, S.,
M. C. Prevost,
J. M. Heard, and O. Schwartz.
1997.
Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity.
Virology
229:295-301[CrossRef][Medline].
|
| 41.
|
Lock, M.,
M. E. Greenberg,
A. J. Iafrate,
T. Swigut,
J. Münch,
F. Kirchhoff,
N. Shohdy, and J. Skowronski.
1999.
Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis.
EMBO J.
18:2722-2733[CrossRef][Medline].
|
| 42.
|
Luo, T., and J. V. Garcia.
1996.
The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are isolate dependent.
J. Virol.
70:6493-6496[Abstract].
|
| 43.
|
Luo, W., and B. M. Peterlin.
1997.
Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus.
J. Virol.
71:9531-9537[Abstract].
|
| 44.
|
Mangasarian, A.,
V. Piguet,
J. K. Wang,
Y. L. Chen, and D. Trono.
1999.
Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking.
J. Virol.
73:1964-1973[Abstract/Free Full Text].
|
| 45.
|
Manninen, A.,
M. Hiipakka,
M. Vihinen,
W. Lu,
B. J. Mayer, and K. Saksela.
1998.
SH3-domain binding function of HIV-1 Nef is required for association with a PAK-related kinase.
Virology
250:273-282[CrossRef][Medline].
|
| 46.
|
Mariani, R., and J. Skowronski.
1993.
CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals.
Proc. Natl. Acad. Sci. USA
90:5549-5553[Abstract/Free Full Text].
|
| 47.
|
Miller, M. D.,
M. T. Warmerdam,
I. Gaston,
W. C. Greene, and M. B. Feinberg.
1994.
The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
J. Exp. Med.
179:101-114[Abstract/Free Full Text].
|
| 48.
|
Nunn, M. F., and J. W. Marsh.
1996.
Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family.
J. Virol.
70:6157-6161[Abstract].
|
| 49.
|
Piguet, V.,
Y. L. Chen,
A. Mangasarian,
M. Foti,
J. L. Carpentier, and D. Trono.
1998.
Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the µ chain of adaptor complexes.
EMBO J.
17:2472-2481[CrossRef][Medline].
|
| 50.
|
Potts, B. J.
1990.
"Mini" reverse transcriptase (RT) assay, p. 103-106.
In
A. Aldovini, and B. D. Walker (ed.), Techniques in HIV research. Stockton, New York, N.Y.
|
| 51.
|
Prince, H. E.,
S. Kleinman,
C. Czaplicki,
J. John, and A. E. Williams.
1990.
Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection.
J. Acquir. Immune Defic. Syndr.
3:525-530.
|
| 52.
|
Regier, D. A., and R. C. Desrosiers.
1989.
The complete nucleotide sequence of a pathogenic molecular clone of SIV.
AIDS Res. Hum. Retrovir.
6:1221-1231[Medline].
|
| 53.
|
Saksela, K.,
G. Cheng, and D. Baltimore.
1995.
Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4.
EMBO J.
14:484-491[Medline].
|
| 54.
|
Saksela, K.
1997.
HIV-1 Nef and host protein kinases.
Front. Biosci.
2:606-618.
|
| 55.
|
Sawai, E. T.,
A. Baur,
H. Struble,
B. M. Peterlin,
J. A. Levy, and C. Cheng-Mayer.
1994.
Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes.
Proc. Natl. Acad. Sci. USA
91:1539-1543[Abstract/Free Full Text].
|
| 56.
|
Schwartz, O.,
V. Marechal,
S. Le Gall,
F. Lemonnier, and J. M. Heard.
1996.
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.
Nat. Med.
2:338-342[CrossRef][Medline].
|
| 57.
|
Skowronski, J.,
D. Parks, and R. Mariani.
1993.
Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene.
EMBO J.
12:703-713[Medline].
|
| 58.
|
Spina, C. A.,
T. J. Kwoh,
M. Y. Chowers,
J. C. Guatelli, and D. D. Richman.
1994.
The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.
J. Exp. Med.
179:115-123[Abstract/Free Full Text].
|
| 59.
|
Stahl-Hennig, C.,
O. Herchenröder,
S. Nick,
M. Evers,
M. Stille-Siegener,
K.-D. Jentsch,
F. Kirchhoff,
T. Tolle,
T. J. Gatesmann,
W. Lüke, and G. Hunsmann.
1990.
Experimental infection of macaques with HIV-2BEN, a novel HIV-2 isolate.
AIDS
4:611-617[Medline].
|
| 60.
|
Stahl-Hennig, C.,
G. Voss,
S. Nick,
H. Petry,
D. Fuchs,
H. Wachter,
C. Coulibaly,
W. Lüke, and G. Hunsmann.
1992.
Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection.
Virology
186:588-596[CrossRef][Medline].
|
| 61.
|
Ten Haaft, P.,
B. Verstrepen,
K. Überla,
B. Rosenwirth, and J. Heeney.
1998.
A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques.
J. Virol.
72:10281-10285[Abstract/Free Full Text].
|
| 62.
|
Whatmore, A. M.,
N. Cook,
G. A. Hall,
S. Sharpe,
E. W. Rud, and M. P. Cranage.
1995.
Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence.
J. Virol.
69:5117-5123[Abstract].
|
| 63.
|
Wyand, M. S.,
K. H. Manson,
M. Garcia-Moll,
D. Monfiori, and R. C. Desrosiers.
1996.
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.
J. Virol.
70:3724-3733[Abstract].
|
| 64.
|
Xu, X. N.,
B. Laffert,
G. R. Screaton,
M. Kraft,
D. Wolf,
W. Kolanus,
J. Mongkolsapay,
A. J. McMichael, and A. S. Baur.
1999.
Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain.
J. Exp. Med.
189:1489-1496[Abstract/Free Full Text].
|
Journal of Virology, May 2000, p. 4155-4164, Vol. 74, No. 9
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schindler, M., Rajan, D., Specht, A., Ritter, C., Pulkkinen, K., Saksela, K., Kirchhoff, F.
(2007). Association of Nef with p21-Activated Kinase 2 Is Dispensable for Efficient Human Immunodeficiency Virus Type 1 Replication and Cytopathicity in Ex Vivo-Infected Human Lymphoid Tissue. J. Virol.
81: 13005-13014
[Abstract]
[Full Text]
-
Vincent, P., Priceputu, E., Kay, D., Saksela, K., Jolicoeur, P., Hanna, Z.
(2006). Activation of p21-activated Kinase 2 and Its Association with Nef Are Conserved in Murine Cells but Are Not Sufficient to Induce an AIDS-like Disease in CD4C/HIV Transgenic Mice. J. Biol. Chem.
281: 6940-6954
[Abstract]
[Full Text]
-
Agopian, K., Wei, B. L., Garcia, J. V., Gabuzda, D.
(2006). A Hydrophobic Binding Surface on the Human Immunodeficiency Virus Type 1 Nef Core Is Critical for Association with p21-Activated Kinase 2. J. Virol.
80: 3050-3061
[Abstract]
[Full Text]
-
Munch, J., Schindler, M., Wildum, S., Rucker, E., Bailer, N., Knoop, V., Novembre, F. J., Kirchhoff, F.
(2005). Primary Sooty Mangabey Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 2 nef Alleles Modulate Cell Surface Expression of Various Human Receptors and Enhance Viral Infectivity and Replication. J. Virol.
79: 10547-10560
[Abstract]
[Full Text]
-
Schindler, M., Munch, J., Kirchhoff, F.
(2005). Human Immunodeficiency Virus Type 1 Inhibits DNA Damage-Triggered Apoptosis by a Nef-Independent Mechanism. J. Virol.
79: 5489-5498
[Abstract]
[Full Text]
-
Schindler, M., Munch, J., Brenner, M., Stahl-Hennig, C., Skowronski, J., Kirchhoff, F.
(2004). Comprehensive Analysis of Nef Functions Selected in Simian Immunodeficiency Virus-Infected Macaques. J. Virol.
78: 10588-10597
[Abstract]
[Full Text]
-
Padua, E., Jenkins, A., Brown, S., Bootman, J., Paixao, M. T., Almond, N., Berry, N.
(2003). Natural variation of the nef gene in human immunodeficiency virus type 2 infections in Portugal. J. Gen. Virol.
84: 1287-1299
[Abstract]
[Full Text]
-
Hiipakka, M., Saksela, K.
(2002). Capacity of simian immunodeficiency virus strain mac Nef for high-affinity Src homology 3 (SH3) binding revealed by ligand-tailored SH3 domains. J. Gen. Virol.
83: 3147-3152
[Abstract]
[Full Text]
-
Kahnt, K., Matz-Rensing, K., Hofmann, P., Stahl-Hennig, C., Kaup, F.-J.
(2002). SIV-associated Lymphomas in Rhesus Monkeys (Macaca mulatta) in Comparison with HIV-associated Lymphomas. Vet Pathol
39: 42-55
[Abstract]
[Full Text]
-
Munch, J., Adam, N., Finze, N., Stolte, N., Stahl-Hennig, C., Fuchs, D., Ten Haaft, P., Heeney, J. L., Kirchhoff, F.
(2001). Simian Immunodeficiency Virus in Which nef and U3 Sequences Do Not Overlap Replicates Efficiently In Vitro and In Vivo in Rhesus Macaques. J. Virol.
75: 8137-8146
[Abstract]
[Full Text]
-
Walk, S. F., Alexander, M., Maier, B., Hammarskjold, M.-L., Rekosh, D. M., Ravichandran, K. S.
(2001). Design and Use of an Inducibly Activated Human Immunodeficiency Virus Type 1 Nef To Study Immune Modulation. J. Virol.
75: 834-843
[Abstract]
[Full Text]
-
Iafrate, A. J., Carl, S., Bronson, S., Stahl-Hennig, C., Swigut, T., Skowronski, J., Kirchhoff, F.
(2000). Disrupting Surfaces of Nef Required for Downregulation of CD4 and for Enhancement of Virion Infectivity Attenuates Simian Immunodeficiency Virus Replication In Vivo. J. Virol.
74: 9836-9844
[Abstract]
[Full Text]